Duearity Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Duearity
Access all reports
Duearity AB is a Swedish medical technology company specializing in innovative solutions for tinnitus treatment. The company's primary product, Tinearity G1, is a medical device designed to alleviate tinnitus symptoms through a non-invasive method that uses white noise delivered via the skull bone, bypassing the ear canal. This approach is based on Tinnitus Retraining Therapy, which has been used clinically for several decades. The company is headquartered in Malmö, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
DEAR
Country
🇸🇪 Sweden